Is there a risk of cytomegalovirus transmission during in vitro fertilization with donated oocytes?

Craig A. Witz, Yanping Duan, William N. Burns, Sally S. Atherton, Robert S Schenken

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Objective: To define the risk of human cytomegalovirus (HCMV) transmission from donated oocytes. Design: Prospective study. Setting: University IVF program. Patient(s): Sixty-seven couples undergoing 72 cycles of IVF-ET. Intervention(s): None. Main Outcome Measure(s): Serum from both partners (women: n = 71; men: n = 60) was obtained for detection of antibodies to HCMV. Semen before preparation (n = 53), sperm after preparation (Percoll gradient; n = 47), cervical mucus aspirated at the time of oocyte aspiration (n = 70), and uninseminated oocytes and embryos not suitable for cryopreservation (n = 568) were frozen in liquid nitrogen. Polymerase chain reaction was used for detection of HCMV (immediate early 1 gene) in all samples collected. Result(s): Serum antibodies to HCMV were found in 62% of the women and 37% of the men tested. Human cytomegalovirus DNA was detected in 25% of the ejaculates and in 19% of the cervical mucus samples. There was no amplification of HCMV DNA from oocytes or embryos. Conclusion(s): Because we were unable to amplify HCMV DNA from any of the oocytes or embryos, it seems unlikely that HCMV is transmissible through oocyte or embryo donation.

Original languageEnglish (US)
Pages (from-to)302-307
Number of pages6
JournalFertility and Sterility
Volume71
Issue number2
DOIs
StatePublished - Feb 1999

Fingerprint

Fertilization in Vitro
Cytomegalovirus
Oocytes
Cervix Mucus
Embryonic Structures
DNA
Embryo Disposition
Oocyte Donation
Oocyte Retrieval
Immediate-Early Genes
Antibodies
Cryopreservation
Semen
Serum
Spermatozoa
Nitrogen
Outcome Assessment (Health Care)
Prospective Studies
Polymerase Chain Reaction

Keywords

  • Cytomegalovirus
  • Donation
  • In vitro fertilization
  • Oocyte
  • Polymerase chain reaction
  • Sperm

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Is there a risk of cytomegalovirus transmission during in vitro fertilization with donated oocytes? / Witz, Craig A.; Duan, Yanping; Burns, William N.; Atherton, Sally S.; Schenken, Robert S.

In: Fertility and Sterility, Vol. 71, No. 2, 02.1999, p. 302-307.

Research output: Contribution to journalArticle

Witz, Craig A. ; Duan, Yanping ; Burns, William N. ; Atherton, Sally S. ; Schenken, Robert S. / Is there a risk of cytomegalovirus transmission during in vitro fertilization with donated oocytes?. In: Fertility and Sterility. 1999 ; Vol. 71, No. 2. pp. 302-307.
@article{7711f3a8d6aa4629aefca5d3aacddf61,
title = "Is there a risk of cytomegalovirus transmission during in vitro fertilization with donated oocytes?",
abstract = "Objective: To define the risk of human cytomegalovirus (HCMV) transmission from donated oocytes. Design: Prospective study. Setting: University IVF program. Patient(s): Sixty-seven couples undergoing 72 cycles of IVF-ET. Intervention(s): None. Main Outcome Measure(s): Serum from both partners (women: n = 71; men: n = 60) was obtained for detection of antibodies to HCMV. Semen before preparation (n = 53), sperm after preparation (Percoll gradient; n = 47), cervical mucus aspirated at the time of oocyte aspiration (n = 70), and uninseminated oocytes and embryos not suitable for cryopreservation (n = 568) were frozen in liquid nitrogen. Polymerase chain reaction was used for detection of HCMV (immediate early 1 gene) in all samples collected. Result(s): Serum antibodies to HCMV were found in 62{\%} of the women and 37{\%} of the men tested. Human cytomegalovirus DNA was detected in 25{\%} of the ejaculates and in 19{\%} of the cervical mucus samples. There was no amplification of HCMV DNA from oocytes or embryos. Conclusion(s): Because we were unable to amplify HCMV DNA from any of the oocytes or embryos, it seems unlikely that HCMV is transmissible through oocyte or embryo donation.",
keywords = "Cytomegalovirus, Donation, In vitro fertilization, Oocyte, Polymerase chain reaction, Sperm",
author = "Witz, {Craig A.} and Yanping Duan and Burns, {William N.} and Atherton, {Sally S.} and Schenken, {Robert S}",
year = "1999",
month = "2",
doi = "10.1016/S0015-0282(98)00433-6",
language = "English (US)",
volume = "71",
pages = "302--307",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Is there a risk of cytomegalovirus transmission during in vitro fertilization with donated oocytes?

AU - Witz, Craig A.

AU - Duan, Yanping

AU - Burns, William N.

AU - Atherton, Sally S.

AU - Schenken, Robert S

PY - 1999/2

Y1 - 1999/2

N2 - Objective: To define the risk of human cytomegalovirus (HCMV) transmission from donated oocytes. Design: Prospective study. Setting: University IVF program. Patient(s): Sixty-seven couples undergoing 72 cycles of IVF-ET. Intervention(s): None. Main Outcome Measure(s): Serum from both partners (women: n = 71; men: n = 60) was obtained for detection of antibodies to HCMV. Semen before preparation (n = 53), sperm after preparation (Percoll gradient; n = 47), cervical mucus aspirated at the time of oocyte aspiration (n = 70), and uninseminated oocytes and embryos not suitable for cryopreservation (n = 568) were frozen in liquid nitrogen. Polymerase chain reaction was used for detection of HCMV (immediate early 1 gene) in all samples collected. Result(s): Serum antibodies to HCMV were found in 62% of the women and 37% of the men tested. Human cytomegalovirus DNA was detected in 25% of the ejaculates and in 19% of the cervical mucus samples. There was no amplification of HCMV DNA from oocytes or embryos. Conclusion(s): Because we were unable to amplify HCMV DNA from any of the oocytes or embryos, it seems unlikely that HCMV is transmissible through oocyte or embryo donation.

AB - Objective: To define the risk of human cytomegalovirus (HCMV) transmission from donated oocytes. Design: Prospective study. Setting: University IVF program. Patient(s): Sixty-seven couples undergoing 72 cycles of IVF-ET. Intervention(s): None. Main Outcome Measure(s): Serum from both partners (women: n = 71; men: n = 60) was obtained for detection of antibodies to HCMV. Semen before preparation (n = 53), sperm after preparation (Percoll gradient; n = 47), cervical mucus aspirated at the time of oocyte aspiration (n = 70), and uninseminated oocytes and embryos not suitable for cryopreservation (n = 568) were frozen in liquid nitrogen. Polymerase chain reaction was used for detection of HCMV (immediate early 1 gene) in all samples collected. Result(s): Serum antibodies to HCMV were found in 62% of the women and 37% of the men tested. Human cytomegalovirus DNA was detected in 25% of the ejaculates and in 19% of the cervical mucus samples. There was no amplification of HCMV DNA from oocytes or embryos. Conclusion(s): Because we were unable to amplify HCMV DNA from any of the oocytes or embryos, it seems unlikely that HCMV is transmissible through oocyte or embryo donation.

KW - Cytomegalovirus

KW - Donation

KW - In vitro fertilization

KW - Oocyte

KW - Polymerase chain reaction

KW - Sperm

UR - http://www.scopus.com/inward/record.url?scp=0032908293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032908293&partnerID=8YFLogxK

U2 - 10.1016/S0015-0282(98)00433-6

DO - 10.1016/S0015-0282(98)00433-6

M3 - Article

C2 - 9988402

AN - SCOPUS:0032908293

VL - 71

SP - 302

EP - 307

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 2

ER -